03.27.24
Nutraceutical contract manufacturer Sirio Pharma will launch a personalized women’s health platform at Vitafoods Europe. The 25 formulations are tailored to a variety of women’s health needs and life stages, with products covering puberty to post-menopause.
The products were each developed with branded ingredients, and are backed by consumer trends, clinical data, and stability studies, the company reports.
“Women’s health focused on individual life stage is the big trend of 2024. Our team researched this early to undertake all the complex formulation options, science, and segmenting of product types. Essentially, we have done the hard work so that our nutraceutical brand partners can launch more quickly to market with first-in-class products,” said Sara Lesina, General Manager Sirio Europe & Americas.
Three products will be on display at Vitafoods Europe. The first is “MenoBalance” gummies, which utilize ADM’s soy isoflavone ingredient, Novasoy. Soy isoflavones are evidenced to reduce the frequency of hot flashes and may help support bone health during menopause. This is the first instance in which Novasoy was incorporated into a gummy format.
“We are excited to partner with Sirio, combining their exceptional gummy manufacturing capabilities with our expertise in science-backed ingredients,” said Paula Limena, VP of Global Marketing at ADM. “This collaboration enables us to create truly unique concepts, offering customers and consumers innovative and quality products that deliver on both taste and nutrition.”
Pre- and postnatal formulations with branded ingredients from KD Nutra and Gnosis by Lesaffre will also be showcased.
The “Me&Mum” postnatal softgel is a product concept featuring DHA, vitamins, minerals, and herbal extracts that help with hair loss, delivered in one easy-to-swallow softgel. The InnoFolate prenatal softgel, which features Sirio’s vegan, carrageenan-free Plantegrity technology, is a prenatal formulation featuring Gnosis by Lesaffre’s Quartefolic, which is evidenced to help maintain folate levels during pregnancy, along with a combination of essential nutrients including DHA.
“We are constantly developing complex formulations made using the highest quality ingredients with the strongest evidence base, bioavailability, and efficacy. It’s also why we are continuously bringing in branded ingredient partners to our newest concepts. We’re working with only elite players in the industry, so that our customers have the best-in-class nutra products for all the consumers who need them,” Lesina said.
The new women’s health line includes both gummies and softgels, spanning general women’s health products like menstrual care, UTI protection, gut health (pre- and postbiotics), sleep health, and weight management. The range also caters to specific life stages and health concerns, like fertility, morning sickness during pregnancy, prenatal care, postnatal symptoms and health (energy, hair loss, fatigue, and brain fog), and a range of menopause support softgels and gummies.
The products were each developed with branded ingredients, and are backed by consumer trends, clinical data, and stability studies, the company reports.
“Women’s health focused on individual life stage is the big trend of 2024. Our team researched this early to undertake all the complex formulation options, science, and segmenting of product types. Essentially, we have done the hard work so that our nutraceutical brand partners can launch more quickly to market with first-in-class products,” said Sara Lesina, General Manager Sirio Europe & Americas.
Three products will be on display at Vitafoods Europe. The first is “MenoBalance” gummies, which utilize ADM’s soy isoflavone ingredient, Novasoy. Soy isoflavones are evidenced to reduce the frequency of hot flashes and may help support bone health during menopause. This is the first instance in which Novasoy was incorporated into a gummy format.
“We are excited to partner with Sirio, combining their exceptional gummy manufacturing capabilities with our expertise in science-backed ingredients,” said Paula Limena, VP of Global Marketing at ADM. “This collaboration enables us to create truly unique concepts, offering customers and consumers innovative and quality products that deliver on both taste and nutrition.”
Pre- and postnatal formulations with branded ingredients from KD Nutra and Gnosis by Lesaffre will also be showcased.
The “Me&Mum” postnatal softgel is a product concept featuring DHA, vitamins, minerals, and herbal extracts that help with hair loss, delivered in one easy-to-swallow softgel. The InnoFolate prenatal softgel, which features Sirio’s vegan, carrageenan-free Plantegrity technology, is a prenatal formulation featuring Gnosis by Lesaffre’s Quartefolic, which is evidenced to help maintain folate levels during pregnancy, along with a combination of essential nutrients including DHA.
“We are constantly developing complex formulations made using the highest quality ingredients with the strongest evidence base, bioavailability, and efficacy. It’s also why we are continuously bringing in branded ingredient partners to our newest concepts. We’re working with only elite players in the industry, so that our customers have the best-in-class nutra products for all the consumers who need them,” Lesina said.
The new women’s health line includes both gummies and softgels, spanning general women’s health products like menstrual care, UTI protection, gut health (pre- and postbiotics), sleep health, and weight management. The range also caters to specific life stages and health concerns, like fertility, morning sickness during pregnancy, prenatal care, postnatal symptoms and health (energy, hair loss, fatigue, and brain fog), and a range of menopause support softgels and gummies.
